Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Teva Pharmaceutical Industries Limited    TEVA

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Teva Pharmaceutical Industries : Up 12% on Opioid Litigation Settlements

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/21/2019 | 02:54pm EST

By Josh Beckerman

Teva Pharmaceutical Industries Ltd. (TEVA) shares recently traded up 12% to $8.41 as it said it reached a framework for a multistate settlement of opioid-related litigation.

Teva would donate buprenorphine naloxone tablets with a value of about $23 billion (at wholesale acquisition cost) over 10 years, and make a cash payment of up to $250 million over 10 years.

Teva and other companies also reached a settlement with two Ohio counties.

Write to Josh Beckerman at josh.beckerman@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED -0.58% 3269 Delayed Quote.-43.94%
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 0.32% 9.33 Delayed Quote.-39.49%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TEVA PHARMACEUTICAL INDUST
08:15aTEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of $1,500,000,000 Offering of ..
AQ
08:15aTEVA PHARMACEUTICAL INDUSTRIES : Announces $1.5 Billion Debt Tender Offers
AQ
11/08TEVA PHARMACEUTICAL INDUSTRIES : Announces $1.5 Billion Debt Tender Offers
BU
11/08TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of $1,500,000,000 Offering of ..
BU
11/07TEVA PHARMACEUTICAL INDUSTRIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCI..
AQ
11/07TEVA PHARMACEUTICAL INDUSTRIES : High Debt, Potential Litigation Costs Face New ..
DJ
11/07Teva Pharmaceutical Names Eli Kalif Chief Financial Officer
DJ
11/07TEVA PHARMACEUTICAL INDUSTRIES : and Celltrion Announce the Availability of TRUX..
BU
11/07TEVA PHARMACEUTICAL INDUSTRIES LTD : Change in Directors or Principal Officers, ..
AQ
11/07TEVA PHARMACEUTICAL INDUSTRIES : Announces Appointment of New Chief Financial Of..
BU
More news
Financials (USD)
Sales 2019 17 174 M
EBIT 2019 4 017 M
Net income 2019 -107 M
Debt 2019 25 619 M
Yield 2019 -
P/E ratio 2019 -100,0x
P/E ratio 2020 5,55x
EV / Sales2019 2,01x
EV / Sales2020 1,87x
Capitalization 8 844 M
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 28
Average target price 9,18  $
Last Close Price 8,10  $
Spread / Highest target 172%
Spread / Average Target 13,4%
Spread / Lowest Target -25,9%
EPS Revisions
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-39.49%8 844
JOHNSON & JOHNSON3.06%344 670
ROCHE HOLDING AG22.19%254 722
MERCK AND COMPANY9.40%211 953
PFIZER-15.12%208 023
NOVARTIS17.78%198 320